Less than 4% of money raised for cancer research targets pediatric cancers, but a D.C.-area charity that’s devoting resources to benefit young cancer victims is sponsoring trials at Children’s National Hospital.
Clinical trials underway for about a year are turning patients’ own immune system cells into an army of soldiers to attack their brain cancer tumors.
“We’re all really excited,” said Dr. Eugene Hwang, associate division chief of oncology at Children’s National Hospital. “The biggest problem would have been if we ran into a big side effect or toxicity signal, and we have not.”